![Lisanne Blauw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisanne Blauw
Fondateur chez
River Biomedics B V I.O.
Profil
Lisanne Blauw is the founder of River Biomedics B V I.O.
since 2020, holding the title of Chief Operations Officer.
Ms. Blauw is currently employed at Thuja Capital Management BV, starting in 2021 as an Associate since 2023.
Education includes an undergraduate degree from the University of Leiden, conferred in 2014, and a graduate degree from Delft University of Technology, conferred in 2019.
Postes actifs de Lisanne Blauw
| Sociétés | Poste | Début |
|---|---|---|
Thuja Capital Management BV
 Thuja Capital Management BV Investment ManagersFinance Thuja Capital invests in companies located in Europe, primarily in the Netherlands. The firm targets companies operating in the fields of biotech, life sciences, nutraceuticals, medtech and digital health technologies. It provides financing for early stage capital requirements. | Analyste en capital-investissement | 01/02/2021 |
River Biomedics B V I.O.
 River Biomedics B V I.O. Medical SpecialtiesHealth Technology Develops human 3D in vitro 3D human heart tissue for pre-clinical drug testing | Fondateur | 01/01/2020 |
Formation de Lisanne Blauw
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delft University of Technology
 Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thuja Capital Management BV
Thuja Capital Management BV Investment ManagersFinance Thuja Capital invests in companies located in Europe, primarily in the Netherlands. The firm targets companies operating in the fields of biotech, life sciences, nutraceuticals, medtech and digital health technologies. It provides financing for early stage capital requirements. | Finance |
River Biomedics B V I.O.
River Biomedics B V I.O. Medical SpecialtiesHealth Technology Develops human 3D in vitro 3D human heart tissue for pre-clinical drug testing | Health Technology |
